GSVUX
Price
$19.65
Change
+$0.22 (+1.13%)
Updated
Jul 31 closing price
Net Assets
479.78M
RMEBX
Price
$64.44
Change
+$0.03 (+0.05%)
Updated
Jul 31 closing price
Net Assets
118.05B
Interact to see
Advertisement

GSVUX vs RMEBX

GSVUX vs RMEBX Comparison Chart in %
View a ticker or compare two or three
VS
GSVUX vs. RMEBX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSVUX is a StrongBuy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 118B vs. GSVUX (480M). RMEBX pays higher dividends than GSVUX: RMEBX (0.99) vs GSVUX (0.79). GSVUX was incepted earlier than RMEBX: GSVUX (11 years) vs RMEBX (12 years). RMEBX (1.07) is less costly to investors than GSVUX (0.87). GSVUX is a more actively managed with annual turnover of: 74.00 vs. RMEBX (30.00). RMEBX has a lower initial minimum investment than GSVUX: RMEBX (250) vs GSVUX (5000000). GSVUX annual gain was more profitable for investors over the last year : 14.66 vs. RMEBX (8.96). RMEBX return over 5 years is better than : 36.13 vs. GSVUX (14.52).
GSVUXRMEBXGSVUX / RMEBX
Total Expense Ratio0.691.0764%
Annual Report Gross Expense Ratio0.871.0781%
Fund Existence11 years12 years-
Gain YTD21.2219.416225%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets480M118B0%
Annual Yield % from dividends0.790.9980%
Returns for 1 year14.668.96164%
Returns for 3 years25.9432.6379%
Returns for 5 years14.5236.1340%
Returns for 10 years37.4490.6441%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEOTX15.100.17
+1.14%
Voya Large Cap Growth Port S2
JRAAX88.86N/A
N/A
Janus Henderson Research A
VLLIX45.39-0.03
-0.07%
Value Line Larger Companies Focus Instl
BHCFX21.68-0.10
-0.46%
Baron Health Care Retail
FBDIX193.96-3.99
-2.02%
Franklin Biotechnology Discovery A